Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kamińska, Karolina
and
Wojaczyńska, Elżbieta
2022.
Synthesis of new chiral N-heterocyclic diselenides and their application in the alkoxyselenylation reaction.
New Journal of Chemistry,
Vol. 46,
Issue. 27,
p.
12918.
Shaikh, Shaukat A.
Priyadarsini, Indira K.
and
Vavilala, Sirisha L.
2022.
Ebselen’s Potential to Inhibit Planktonic and Biofilm Growth of Neisseria
mucosa.
Current Chemical Biology,
Vol. 16,
Issue. 1,
p.
61.
Chen, Qian
Shen, Liangfang
and
Li, Shan
2023.
Emerging role of inositol monophosphatase in cancer.
Biomedicine & Pharmacotherapy,
Vol. 161,
Issue. ,
p.
114442.
Mukem, Sirirak
Sayoh, Ibrahim
Maungchanburi, Saowanee
Thongbuakaew, Tipsuda
and
Chan, Kim Wei
2023.
Ebselen, Iron Uptake Inhibitor, Alleviates Iron Overload-Induced Senescence-Like Neuronal Cells SH-SY5Y via Suppressing the mTORC1 Signaling Pathway.
Advances in Pharmacological and Pharmaceutical Sciences,
Vol. 2023,
Issue. ,
p.
1.
Maślanka, Marta
and
Mucha, Artur
2023.
Antibacterial Activity of Ebselen.
International Journal of Molecular Sciences,
Vol. 24,
Issue. 2,
p.
1610.
Raheem, Shabnam
Richu
Jan, Tabee
Mustafa, Mohd
Peerzada, G.M.
Kumar, Ashwani
and
Rizvi, Masood Ahmad
2023.
Multiparametric Investigations on Solvation Behaviour and Spectral Shifts of Symmetric Aromatic Diselenides: A case study of Diphenyldiselenide.
Physics and Chemistry of Liquids,
Vol. 61,
Issue. 6,
p.
421.
Macegoniuk, Katarzyna
Tabor, Wojciech
Mazzei, Luca
Cianci, Michele
Giurg, Mirosław
Olech, Kamila
Burda-Grabowska, Małgorzata
Kaleta, Rafał
Grabowiecka, Agnieszka
Mucha, Artur
Ciurli, Stefano
and
Berlicki, Łukasz
2023.
Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action.
Journal of Medicinal Chemistry,
Vol. 66,
Issue. 3,
p.
2054.
Morán-Serradilla, Cristina
Plano, Daniel
Sanmartín, Carmen
and
Sharma, Arun K.
2024.
Selenization of Small Molecule Drugs: A New Player on the Board.
Journal of Medicinal Chemistry,
Vol. 67,
Issue. 10,
p.
7759.
Alves de Lima e Silva, Agostinho
Rio-Tinto, André
and
Behzadi, Payam
2024.
Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms.
Interdisciplinary Perspectives on Infectious Diseases,
Vol. 2024,
Issue. ,
p.
1.
Elmorsy, Elsayed A.
Saber, Sameh
Hamad, Rabab S.
Abdel-Reheim, Mustafa Ahmed
El-kott, Attalla F.
AlShehri, Mohammed A.
Morsy, Kareem
Salama, Salama A.
and
Youssef, Mahmoud E.
2024.
Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies.
European Journal of Pharmaceutical Sciences,
Vol. 203,
Issue. ,
p.
106939.
Barbosa, Nilda V.
Aschner, Michael
Tinkov, Alexey A.
Farina, Marcelo
and
Rocha, João Batista Teixeira da
2024.
Should ebselen be considered for the treatment of mercury intoxication? A minireview.
Toxicology Mechanisms and Methods,
Vol. 34,
Issue. 1,
p.
1.
Dötsch, Lara
Davies, Caitlin
Hennes, Elisabeth
Schönfeld, Julia
Kumar, Adarsh
Guita, Celine Da Cruz Lopes
Ehrler, Johanna H.M.
Hiesinger, Kerstin
Thavam, Sasikala
Janning, Petra
Sievers, Sonja
Knapp, Stefan
Proschak, Ewgenij
Ziegler, Slava
and
Waldmann, Herbert
2024.
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Journal of Medicinal Chemistry,
Vol. 67,
Issue. 6,
p.
4691.
Baskar, Sugumar
Bharathiraja, Pradhapsingh
and
Rajendra Prasad, N.
2024.
Sensitization of Multidrug Resistant Cancer Cells to Doxorubicin Using Ebselen by Disturbing Cellular Redox Status.
Cell Biochemistry and Function,
Vol. 42,
Issue. 7,
Morán-Serradilla, Cristina
Sanmartín, Carmen
Sharma, Arun K.
and
Plano, Daniel
2025.
Drug Discovery Stories.
p.
217.